Phoenix PharmaLabs Announces Investment Offering to Support Additional Research of Non-Addictive Opioid
PPLadmin 2018-10-17T14:38:40+00:00BioSpace Global Banking & Finance Review
About PPLadmin
This author has not yet filled in any details.So far PPLadmin has created 11 blog entries.
How to fight drug addiction: the shift to prescription drugs
PPLadmin 2018-09-27T16:33:05+00:00Full Article
How a stepson’s addiction drove a father to try to develop a safer opioid
PPLadmin 2018-09-27T16:32:29+00:00Full Article
One Stepfather’s Quest: The Search For An Opioid That Won’t Lead To Addiction
PPLadmin 2018-09-27T16:31:15+00:00Full Article
Novel Non-Addictive Opioid Described at CPDD Annual Meeting in San Diego
PPLadmin 2018-09-27T16:30:12+00:00Download PDF
Phoenix PharmaLabs Exec Describes Novel Non-Addictive Opioid
PPLadmin 2018-09-27T16:28:58+00:00Full Article
In Vitro and In Vivo Profile of PPL-101 and PPL-103: Mixed Opioid Partial Agonist Analgesics with Low Abuse Potential.
PPLadmin 2018-09-27T16:28:11+00:00Full Article
Research Declares Phoenix PharmaLabs’ Opioid PPL-103 Safe
PPLadmin 2018-09-27T16:24:38+00:00Full Article
n Vitro and In Vivo Profile of PPL-101 and PPL-103: Mixed Opioid Partial Agonist Analgesics with Low Abuse Potential
PPLadmin 2018-09-27T16:22:43+00:00Full Article
Phoenix Pharma Labs Technology Transfer Grant
PPLadmin 2018-08-14T18:33:22+00:00Phoenix PharmaLabs has received a Technology Transfer Grant from the National Institutes of Health to evaluate its lead compound as a potential treatment for cocaine addiction. Dr. Larry Toll, our CTO, was recruited earlier this year by Florida Atlantic University to become the University's first recruit under the 21st Century World Class Scholars Program established [...]
Load More Posts